Home  >  Products  >  LTB (lymphotoxin beta (TNF superfamily, member 3)) Blocking Peptide (the N terminal of LTB)(100ug)
LTB (lymphotoxin beta (TNF superfamily, member 3)) Blocking Peptide (the N terminal of LTB)(100ug)

LTB (lymphotoxin beta (TNF superfamily, member 3)) Blocking Peptide (the N terminal of LTB)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LTB Antibody(ARP45280_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP45280
Size: 100ug
Weight: 25kDa
Gene: 4050
Format: Lyophilized powder
Target: Lymphotoxin beta is a type II membrane protein of the TNF family. It anchors lymphotoxin-alpha to the cell surface through heterotrimer formation. The predominant form on the lymphocyte surface is the lymphotoxin-alpha 1/beta 2 complex (e.g. 1 molecule alpha/2 molecules beta) and this complex is the primary ligand for the lymphotoxin-beta receptor. The minor complex is lymphotoxin-alpha 2/beta 1. LTB is an inducer of the inflammatory response system and involved in normal development of lymphoid tissue. Lymphotoxin-beta isoform b is unable to complex with lymphotoxin-alpha suggesting a function for lymphotoxin-beta which is independent of lympyhotoxin-alpha. Alternative splicing results in multiple transcript variants encoding different isoforms.
Alternative names: TNFC; TNFSF3; p33